Series A startups in China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zhongke Ruijian | Hangzhou | Series A | $14.0M | 2026-11-03 |
| Utarn Technology | Hangzhou | Series A | $15.0M | 2026-10-22 |
| ExponTech | Luoyang | Series A | $15.0M | 2026-10-20 |
| EdgeRock | Wuqing | Series A | $14.9M | 2026-10-16 |
| Aibo Medical Robot | Shenzhen | Series A | $14.1M | 2026-10-15 |
| MaxSense Technology | Shanghai | Series A | $14.9M | 2026-09-29 |
| Wuwen Zhike | Beijing | Series A | $14.6M | 2026-09-09 |
| XPENG Robotics | Guangzhou | Series A | $900.0M | 2026-08-24 |
8 rows of the CSV in 5 of its 18 columns.
- The 7,132 series a startups in China have raised $32.4B in total.
- 936 of them closed their most recent round in the last 12 months, $11.1B combined.
- The largest of those rounds is XPENG Robotics' $900.0M Series A, dated August 2026.
- The most recent is Afana Biotechnology's $50.0M Series A on 6 November 2026.
- IDG Capital is an investor in 60 of them, more than any other fund.
- Software is the most common sector, with 1,999 companies (28%).
- 20% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (41% of companies with a recorded size).
- 9 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 7,132| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Zhongke Ruijian | Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. | Artificial intelligence | Hangzhou | Series A | $14.0M | 2026-11-03 | $14.0M | Fortune Venture Capital | 11 to 50 | 2020 |
| Utarn Technology | Utarn Technology develops spiking neural network technology. | Artificial intelligence | Hangzhou | Series A | $15.0M | 2026-10-22 | $15.0M | QF Capital, Huagai Capital, Co-Power Capital Management +1 | 51 to 100 | 2019 |
| ExponTech | ExponTech provides data infrastructure solutions built on distributed architecture. | Hardware | Luoyang | Series A | $15.0M | 2026-10-20 | $43.6M | Cowin Capital, Future Capital Discovery Fund, Ameba Capital +2 | 101 to 250 | 2020 |
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Shenzhen | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| MaxSense Technology | MaxSense Technology develops autonomous driving systems and industrial operation optimization software. | Software | Shanghai | Series A | $14.9M | 2026-09-29 | $15.3M | Leading Capital, Yijin Capital, Galaxy Capital | 11 to 50 | 2015 |
| Wuwen Zhike | Wuwen Zhike provides intelligent driving services. | Artificial intelligence | Beijing | Series A | $14.6M | 2026-09-09 | $14.6M | TusStar, Leaguer Venture Capital, Leaguer Financial +1 | 51 to 100 | 2022 |
| XPENG Robotics | XPENG Robotics develops AI-powered smart robots and robotic technology. | Artificial intelligence | Guangzhou | Series A | $900.0M | 2026-08-24 | $1.4B | IDG Capital | 10,001 or more | 2016 |
| Xincan Technology | Xincan Technology develops low-power HCI and digital-analog hybrid SOC solutions. | Hardware | Shenzhen | Series A | $14.9M | 2026-08-23 | $16.3M | Jiupai Capital | 11 to 50 | 2020 |
| Sealien | Sealien researches, develops, engineers, and leases deep-sea industrial robots. | Artificial intelligence | Guangzhou | Series A | $74.1M | 2026-08-13 | $74.1M | ECC Capital, Guangzhou Financial Holding Fund Management, Wanlian Tianze | 11 to 50 | 2021 |
| Garen Semiconductor | Garen Semiconductor researches, produces, and sells semiconductor materials including gallium oxide. | Hardware | Hangzhou | Series A | $13.9M | 2026-08-13 | $13.9M | Puhua Capital, Jiuzhi Ziben | 2022 | |
| Gongyan Tuoxin | Gongyan Tuoxin designs and manufactures optoelectronic chips. | Hardware | Suzhou | Series A | $14.8M | 2026-08-11 | $28.5M | Cowin Venture, Huashan Capital, China Fellow Partners +1 | 51 to 100 | 2023 |
| Yilanke | Yilanke develops flexible interconnection equipment and multi-port energy router products. | Energy | Shenzhen | Series A | $1.4M | 2026-08-10 | $1.4M | Timesbole, Kinzon Capital, Shenzhen Angel FOF | 51 to 100 | 2021 |
| Startorus Fusion | Startorus Fusion builds commercial controllable fusion reactors to generate electricity. | Energy | Xian Shi | Series A | $130.4M | 2026-08-08 | $347.3M | Shunwei Capital, K2VC, CAS Star | 101 to 250 | 2021 |
| Suzhou Xizhi Technology | Suzhou Xizhi Technology develops and manufactures automotive-grade power and power module components. | Hardware | Suzhou | Series A | $14.8M | 2026-08-07 | $42.4M | Hillhouse Investment, Blue Lake Capital, Shang Qi Capital +2 | 101 to 250 | 2021 |
| Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Beijing | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| Blue Wave | Blue Wave develops 5G and AIoT chips, SoCs, and communication system technologies for mobile and vehicle applications. | Hardware | Hangzhou | Series A | $13.7M | 2026-08-01 | $43.9M | Oriental Fortune Capital, SAIF Partners, Zhuoyuan Capital +1 | 2021 | |
| Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Minhang | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
| Polarisic | Polarisic designs chips and manufactures image sensors for various applications. | Hardware | Wuhan | Series A | $14.7M | 2026-07-10 | $51.0M | Legend Capital, Hongtai Fund, Boyu Capital +2 | 51 to 100 | 2021 |
| Xingfan Intelligence | Xingfan Intelligence provides one-stop industry AIGC technology services. | Artificial intelligence | Chengdu | Series A | $44.2M | 2026-07-06 | $59.4M | Peakview Capital, ECC Capital | 11 to 50 | 2021 |
| SynMetaBio | SynMetaBio develops synthetic biological materials by combining synthetic biology with material design. | Biotech | Shanghai | Series A | $14.7M | 2026-07-06 | $16.1M | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2021 |
| Tuoyuan Wisdom | Tuoyuan Wisdom develops AI systems using multi-modal generation, large language models, and causal reasoning technology. | Artificial intelligence | Futian | Series A | $13.7M | 2026-07-02 | $13.7M | Yinxinggu Capital, Zhuoyuan Capital, Ginkgo Capital | 11 to 50 | 2021 |
| Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Hangzhou | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| Lingtai Krypton Biotechnology | Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. | Biotech | Shuangliu | Series A | $13.7M | 2026-06-26 | $13.7M | Legend Capital, Guosheng Capital, Firefly Haoyue | 11 to 50 | 2021 |
| Hylic | Hylic manufactures solid-state lithium-ion batteries. | Energy | Suzhou | Series A | $13.8M | 2026-06-25 | $13.8M | Rongyu Capital | 11 to 50 | 2023 |
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Haidian | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| Haimai Medical | Haimai Medical develops tissue engineering and regenerative medicine technologies. | Health care | Suzhou | Series A | $14.3M | 2026-06-12 | $14.3M | IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 | 51 to 100 | 2021 |
| Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Shanghai | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Shenzhen | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| Qixiangyun | Qixiangyun develops standard financial and taxation software components. | Fintech | Haidian | Series A | $14.6M | 2026-04-08 | $28.9M | Eight Roads Ventures, Guangzhou SIE Consulting | 2021 |
Table 1. Series A startups in China: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 7,132.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XPENG Robotics | XPENG Robotics develops AI-powered smart robots and robotic technology. | Artificial intelligence | Guangzhou | Series A | $900.0M | 2026-08-24 | $1.4B | IDG Capital | 10,001 or more | 2016 |
| 2 | Startorus Fusion | Startorus Fusion builds commercial controllable fusion reactors to generate electricity. | Energy | Xian Shi | Series A | $130.4M | 2026-08-08 | $347.3M | Shunwei Capital, K2VC, CAS Star | 101 to 250 | 2021 |
| 3 | MoleculeMind | MoleculeMind combines artificial intelligence with biotechnology to develop new drugs and biological solutions. | Artificial intelligence | Haidian | Series A | $86.0M | 2026-06-17 | $114.6M | Shenzhen Capital Group, Lenovo Capital and Incubator Group (LCIG), Sense Capital | 51 to 100 | 2022 |
| 4 | Sealien | Sealien researches, develops, engineers, and leases deep-sea industrial robots. | Artificial intelligence | Guangzhou | Series A | $74.1M | 2026-08-13 | $74.1M | ECC Capital, Guangzhou Financial Holding Fund Management, Wanlian Tianze | 11 to 50 | 2021 |
| 5 | Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Shanghai | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| 6 | Xingfan Intelligence | Xingfan Intelligence provides one-stop industry AIGC technology services. | Artificial intelligence | Chengdu | Series A | $44.2M | 2026-07-06 | $59.4M | Peakview Capital, ECC Capital | 11 to 50 | 2021 |
| 7 | SEIDA | SEIDA provides back end development and electronic design automation manufacturing tools for integrated circuit design. | Hardware | Hangzhou | Series A | $43.3M | 2026-03-09 | $43.3M | Phoenix Tree Capital Partners | 2021 | |
| 8 | Degron Therapeutics | Degron Therapeutics discovers molecular glue degraders for cancer treatment. | Biotech | Shanghai | Series A | $40.0M | 2026-05-14 | $94.0M | Baidu Ventures, BioVenture, New Alliance Capital +2 | 101 to 250 | 2021 |
| 9 | Phil Rivers Technology | Phil Rivers Technology provides AI solutions for pharmaceutical research and development. | Artificial intelligence | Beijing | Series A | $29.6M | 2026-08-05 | $57.3M | Insight Capital | 51 to 100 | 2015 |
| 10 | Tianhu Technology | Tianhu Technology uses computational chemistry and artificial intelligence to design new drug molecules. | Artificial intelligence | Minhang | Series A | $29.0M | 2026-07-13 | $54.2M | Qiming Venture Partners, GSR United Capital, 3E Bioventures | 11 to 50 | 2021 |
Table 2. Series A startups in China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | IDG Capital | Private equity firm | Beijing, China | 60 | 1% | 2 | XPENG Robotics, Haimai Medical |
| 2 | Matrix Partners China | Venture capital firm | Beijing, China | 48 | 1% | ||
| 3 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 44 | 1% | 1 | MoleculeMind |
| 4 | ZhenFund | Entrepreneurship program | Beijing, China | 44 | 1% | ||
| 5 | Sinovation Ventures | Venture capital firm | Beijing, China | 34 | 0% | 1 | True Talents For China (TTC) |
| 6 | Shunwei Capital | Venture capital firm | Beijing, China | 32 | 0% | 3 | Startorus Fusion, Jiana Energy, Neurodome |
| 7 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | 28 | 0% | 1 | Blue Wave |
| 8 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 28 | 0% | 3 | Tianhu Technology, Prime Lifescience, PRCXI Biotechnology |
| 9 | K2VC | Angel group | Beijing, China | 27 | 0% | 1 | Startorus Fusion |
| 10 | Cowin Capital | Private equity firm | Shenzhen, China | 26 | 0% | 1 | ExponTech |
| 11 | Addor Capital | Venture capital firm | Nanjing, China | 25 | 0% | 1 | Alpha Better |
| 12 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 24 | 0% | 2 | Zhongke Ruijian, Dishi Medical |
| 13 | Gaorong Capital | Venture capital firm | Wangjing, China | 24 | 0% | 3 | BioGeometry, Huayi Quantum, Allink Biotherapeutics |
| 14 | Source Code Capital | Venture capital firm | Chaoyang, China | 23 | 0% | 1 | True Talents For China (TTC) |
| 15 | Plum Ventures | Venture capital firm | Changzhou, China | 23 | 0% |
Table 3. Series A startups in China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 1,999 | 28% | $9.8B |
| Hardware | 1,455 | 20% | $9.4B |
| Health care | 1,172 | 16% | $11.1B |
| Commerce | 667 | 9% | $589.5M |
| Artificial intelligence | 529 | 7% | $7.5B |
| Biotech | 485 | 7% | $6.9B |
| Fintech | 439 | 6% | $2.6B |
| Education | 381 | 5% | $369.0M |
| Energy | 275 | 4% | $1.6B |
| Cybersecurity | 105 | 1% | $51.7M |
Table 4. Series A startups in China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 7,132 | 100% | $3.0M |
Table 5. Series A startups in China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Series A startups in China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 18 | 2% | $450.5M |
| October 2026 | 56 | 6% | $692.5M |
| September 2026 | 47 | 5% | $955.7M |
| August 2026 | 86 | 9% | $2.1B |
| July 2026 | 66 | 7% | $934.7M |
| June 2026 | 68 | 7% | $1.2B |
| May 2026 | 66 | 7% | $942.9M |
| April 2026 | 52 | 6% | $604.3M |
| March 2026 | 89 | 10% | $569.3M |
| February 2026 | 88 | 9% | $1.0B |
| January 2026 | 130 | 14% | $568.2M |
| December 2025 | 108 | 12% | $753.3M |
| November 2025 | 62 | 7% | $217.1M |
Table 7. Series A startups in China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 766 | 11% | $10.1B |
| 2025 | 820 | 11% | $4.7B |
| 2024 | 363 | 5% | $2.7B |
| 2023 | 407 | 6% | $4.2B |
| 2022 | 401 | 6% | $4.4B |
| 2021 | 290 | 4% | $4.8B |
Table 8. Series A startups in China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 390 | 6% |
| 2020 to 2022 | 985 | 14% |
| 2015 to 2019 | 2,551 | 36% |
| 2010 to 2014 | 1,961 | 28% |
| Before 2010 | 1,105 | 16% |
Table 9. Series A startups in China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 602 | 11% |
| 11 to 50 | 2,354 | 41% |
| 51 to 100 | 1,052 | 18% |
| 101 to 250 | 895 | 16% |
| 251 to 500 | 466 | 8% |
| 501 to 1,000 | 168 | 3% |
| 1,001 to 5,000 | 142 | 2% |
| 5,001 to 10,000 | 18 | 0% |
| 10,001 or more | 24 | 0% |
Table 10. Series A startups in China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series A and its headquarters is in China. On 16 November 2026 that is 7,132 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 7,132 rows: 2,289 have no round amount, 1 no city and 5,174 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series a startups in China are on the list?
- 7,132, in the file dated 16 November 2026. 936 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 7,132 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 72 hours, $599.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.